BioMarin Pharmaceuticals BMRN Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent
Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's other comprehensive income (loss), tax, portion attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's other comprehensive income (loss), tax, portion attributable to parent?
- BioMarin Pharmaceuticals (BMRN) reported other comprehensive income (loss), tax, portion attributable to parent of -$1.12M in Q1 2026.
- How has BioMarin Pharmaceuticals's other comprehensive income (loss), tax, portion attributable to parent changed year-over-year?
- BioMarin Pharmaceuticals's other comprehensive income (loss), tax, portion attributable to parent decreased by 425.8% year-over-year, from $345K to -$1.12M.